318 related articles for article (PubMed ID: 18519680)
21. A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase protein microarray.
Park MY; Choi SC; Lee HS; Kim D; Baek KE; Kim JT; Lim JS; Yeom YI; Chung JW; Kim JW; Myung PK; Lee HG; Kim JW; Song EY
Clin Chim Acta; 2008 Jan; 387(1-2):84-9. PubMed ID: 17936257
[TBL] [Abstract][Full Text] [Related]
22. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS
Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041
[TBL] [Abstract][Full Text] [Related]
24. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production.
Oh SS; Kim D; Kim DH; Chang HH; Sohn KC; Kim KH; Jung SH; Lee BK; Kim JH; Kim KD
Carcinogenesis; 2012 Oct; 33(10):1882-8. PubMed ID: 22696597
[TBL] [Abstract][Full Text] [Related]
25. Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.
Gao L; Wu GJ; Liu XW; Zhang R; Yu L; Zhang G; Liu F; Yu CG; Yuan JL; Wang H; Yao LB
Cancer Lett; 2011 Nov; 310(1):94-100. PubMed ID: 21741166
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
Feng L; Xie Y; Zhang H; Wu Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
[TBL] [Abstract][Full Text] [Related]
27. [Expression and significance of new candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colorectal cancer].
Shi H; Wang WZ; Yao LB; Zhang J; Yin Q; Xu CS; Chu DK; Dong GL; Zhang HW; Li JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):281-4. PubMed ID: 19434539
[TBL] [Abstract][Full Text] [Related]
28. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
29. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Wu TT; Hsieh YH; Hsieh YS; Liu JY
J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
[TBL] [Abstract][Full Text] [Related]
30. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
31. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
33. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI
Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
35. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
36. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
38. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
[TBL] [Abstract][Full Text] [Related]
39. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
40. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
